Quarterly report pursuant to Section 13 or 15(d)

Schedule of Segment Information (Details)

v3.21.2
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]          
Revenues, net $ 9,142 $ 3,623 $ 24,413 $ 5,511  
Consolidated cost of revenue 4,676 2,344 11,020 3,817  
Total Depreciation and amortization expense 395 5 743 10  
Operating and other expenses 5,466 1,204 12,988 2,423  
Total income (loss) from continuing operations, before income taxes (1,395) 70 (338) (739)  
Net income (loss) (1,395) 70 (338) (739)  
Total assets 76,323   76,323   $ 31,405
Diagnostic Services [Member]          
Segment Reporting Information [Line Items]          
Revenues, net 7,537 20,274  
Consolidated cost of revenue 3,479 7,824  
Total Depreciation and amortization expense 392 737  
Total income (loss) from continuing operations, before income taxes 1,164 4,004  
Total assets 32,222   32,222   13,410
Consumer Products [Member]          
Segment Reporting Information [Line Items]          
Revenues, net 1,605 3,623 4,139 5,511  
Consolidated cost of revenue 1,197 2,344 3,196 3,817  
Total Depreciation and amortization expense 3 5 6 10  
Total income (loss) from continuing operations, before income taxes 540 1,274 505 1,684  
Total assets 5,294   5,294   6,261
Unallocated Corporate [Member]          
Segment Reporting Information [Line Items]          
Total income (loss) from continuing operations, before income taxes (3,099) $ (1,204) (4,847) $ (2,423)  
Total assets $ 38,807   $ 38,807   $ 11,734